![Javier Szwarcberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 974 335 $ al 31/05/2026
Javier Szwarcberg is Chief Executive Officer & Executive Director at Spruce Biosciences, Inc. since 2022.
Formerly, Dr. Szwarcberg was Group VP, Head-Product & Portfolio Development at BioMarin Pharmaceutical, Inc. from 2020 to 2022, Senior VP-Program & Portfolio Management at Ultragenyx Pharmaceutical, Inc. from 2017 to 2020, and Vice President-Clinical & Business Development at Horizon Therapeutics Ltd. (Ireland) from 2016 to 2017.
Education includes a doctorate from Universidad de Buenos Aires and graduate studies at Harvard T.H.
Chan School of Public Health.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC. 1,78 % | 24/03/2026 | 19.004 ( 1,78 % ) | 974 335 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Director Ejecutivo | 03/01/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2022 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/02/2020 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Director Técnico/Científico/I+D | 01/10/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
